JPMorgan Chase & Co. news

   Watch this stock
Showing stories 11 - 20 of about 207   

Articles published

JPM 56.05 +0.24 (0.43%)
price chart
Weekly CFO Sells Highlight: AthenaHealth Inc, Gilead Sciences Inc, JPMorgan ...
According to GuruFocus Insider Data , the recent CFO sales were: AthenaHealth Inc, Gilead Sciences Inc, and JPMorgan Chase & Co. AthenaHealth Inc ( ATHN ): CFO and SVP Timothy M Adams sold 30,000 Shares. On 02/18/2014, CFO and SVP Timothy M ...
Related articles »  
Johnson Controls Rating Reiterated by JPMorgan Chase & Co. (JCI)
Johnson Controls Inc logo JPMorgan Chase & Co. reiterated their neutral rating on shares of Johnson Controls (NYSE:JCI) in a research report sent to investors on Tuesday morning, American Banking News reports.
Kilroy Realty Corp. Receives �Overweight� Rating from JPMorgan Chase & ...  WKRB News
Education Realty Trust Stock Rating Reaffirmed by JPMorgan Chase & Co. (EDR)  Mideast Time
Related articles »  
JPMorgan Chase gives $10 million to LA job training programs
JPMorgan Chase & Co. said Monday it would invest $10 million to support job training programs in Los Angeles. The money will be allocated over five years.
Boston Properties Receives �Neutral� Rating from JPMorgan Chase & Co. (BXP)
Boston Properties, Inc. logo JPMorgan Chase & Co. reiterated their neutral rating on shares of Boston Properties (NYSE:BXP) in a research report released on Tuesday morning, American Banking News reports.
PPG Industries Receives �Overweight� Rating from JPMorgan Chase & Co. (PPG)
PPG Industries (NYSE:PPG)'s stock had its �overweight� rating reaffirmed by research analysts at JPMorgan Chase & Co. in a report released on Tuesday, Stock Ratings Network.com reports. They currently have a $208.00 price objective on the stock.
PPG Industries Rating Reiterated by JPMorgan Chase & Co. (PPG)  Watch List News (press release)
Related articles »  
JPMorgan Chase & Co. Increases Valeant Pharmaceuticals Intl Price Target to ...
Valeant Pharmaceuticals Intl Inc logo Equities researchers at JPMorgan Chase & Co. hoisted their price target on shares of Valeant Pharmaceuticals Intl (NYSE:BVF) from $170.00 to $180.00 in a research report issued on Wednesday, AnalystRatingsNetwork ...
Related articles »  
Investment Analysts' Recent Ratings Updates for JPMorgan Chase & Co. (JPM)
JPMorgan Chase & Co. had its �neutral� rating reaffirmed by analysts at Zacks. They now have a $58.00 price target on the stock.
JPMorgan Chase & Co. Reiterates Overweight Rating for Lloyds Banking Group ...
Lloyds Banking Group PLC logo Lloyds Banking Group PLC (LON:LLOY)'s stock had its �overweight� rating reiterated by equities researchers at JPMorgan Chase & Co. in a research report issued on Wednesday, American Banking News reports.
Ferrexpo Plc Given Underweight Rating at JPMorgan Chase & Co. (FXPO)  Ticker Report
Burberry Group plc Given Neutral Rating at JPMorgan Chase & Co. (BRBY)  Mideast Time
Related articles »  
Evraz Upgraded by JPMorgan Chase & Co. to Neutral (EVR)
Evraz logo Evraz (LON:EVR) was upgraded by stock analysts at JPMorgan Chase & Co. to a �neutral� rating in a report issued on Tuesday, American Banking News reports.
JPMorgan fails to end lawsuit over London Whale losses
The cases in the U.S. District Court, Southern District of New York are In re: JPMorgan Chase & Co Securities Litigation, No.
JP Morgan Chase & Co. (NYSE:JPM) Facing Lawsuit Over London Whale Scandal  WallStreetPR
JPMorgan Wins Dismissal of Employees' Whale Pension Suit  Bloomberg
Related articles »